Gilead Gets Letairis Approval, Potential Best In Class For PAH Gilead Gets Letairis Approval, Potential Best In Class For PAH
Gilead Gets Letairis Approval, Potential Best In Class For PAH
Home
Google
:: Web Directory
:: pharmac, manufacturing News
:: Free RSS news
:: Free Newsletter
:: Tell a Friend
Clientfinder.com
Productfinder.com
Nome
Search
Powered by
Google

:: Free RSS news
pharmac, manufacturing can now be syndicated quickly and easily using our new Really Simple Syndication feeds.
xml

:: Tell a Friend

Your Name
Your Email
Your Friend's Name
Your Friend's Email



:: pharmac, manufacturing News
Gilead Gets Letairis Approval, Potential Best In Class For PAH

BioWorld Online, GA -By Trista Morrison While Encysive Pharmaceuticals Inc. received a third approvable letter for Thelin (sitaxsentan sodium) on Friday, Gilead Sciences Inc. ...<br><img src="/images/chart_7777cc3.gif" class="ticker-icon" width="14" height="12"><a href="http://finance.google.com/finance?q=GILD&client=news" class="rich">GILD</a><a href="http://www.news-medical.net/?id=26431" id=r-10_0>Solvay Pharmaceuticals submits supplemental NDA for AndroGel</a><br>News-Medical.net, Australia - 23 minutes ago<br>Solvay Pharmaceuticals also is seeking an additional indication for AndroGel in the treatment of Constitutional Delay in Growth and Puberty (CDGP) in male ...

::Read the Full Article


[ Privacy Policy ] [ Disclaimer ] [ Advertise with us ] [ Contact Us ]

Copyright (c) 2005 Tradenet srl Italy
P.I IT 02212120246

Powered by TrADE-Net®

Google